Click here to go to the previous page
Partnering for Impact in Global Health
Program Code:
330
Date:
Wednesday, June 27, 2012
Time:
10:00 AM to 11:30 AM
EST
CHAIR
:
Nicole Bates, Deputy Director, Global Health Policy and Advocacy, Bill & Melinda Gates Foundation, United States
PRESENTER
(S):
Ken Duncan,
Bill & Melinda Gates Foundation, United States
Ken Duncan leads drug discovery across a number of therapeutic areas including TB, malaria, human African trypanosomiasis, helminth infections and diarrheal disease. He began working for the foundation in 2004 and before that he spent 16 years with GlaxoSmithKline.
|
Amrit Ray,
Janssen Research & Development, LLC, United States
Dr.Ray is VP-Medical Safety, Epidemiology & MedAffairs Mature Products, and Operating Chair for BMS medical governance. He previously led Phase3/4 development for several drugs at Pfizer R&D. He has BS,MD(Edinburgh) and MBA(Dartmouth) degrees, and experience as a Clinician and a McKinsey Consultant.
|
David Reddy, Medicines For Malaria Venture (MMV), Switzerland
Vincent Ahonkhai, Bill & Melinda Gates Foundation, United States
Description
This forum will provide an overview of the Bill & Melinda Gates Foundation's work and describe its "Decade of Vaccines" effort. Panelists will also address a partnership for tuberculosis drug discovery, examples of product development partnerships, and a project on postmarket drug and vaccine surveillance in low- and middle-income countries.
Learning Objectives:
Describe the "Decade of Vaccines" work
Discuss the partnership for tuberculosis drug discovery, product development, and postmarketing drug and vaccine surveillance in low- and middle-income countries.